For years, the standard treatment has been a medication called heparin, which stops blood clots from forming. This type of medicine is called an anticoagulant (also known as a blood thinner).
If heparin is given continuously through a vein (IV), you must stay in the hospital. However, newer forms of heparin that can be given by injection once or twice a day can sometimes be used. You may not need to stay in the hospital as long, or at all, if you are prescribed this newer form of heparin.
The drug warfarin is usually prescribed along with heparin. Warfarin is taken by mouth and is usually used for long-term therapy. It takes several days to fully work. Heparin is continued until the warfarin has been fully effective for at least 24 hours. People usually take warfarin for a minimum of 3 months, but sometimes they must take it for the rest of their lives, depending on their risk for another clot.
You will need frequent lab tests to check the thickness of your blood when you first start taking warfarin. This lets your health care provider properly adjust your dose.
In rare cases, surgery may be needed if medicines do not work. Surgery may involve:
Many DVTs disappear without a problem, but they can return. Some people may have long-term pain and swelling in the leg known as post-phlebitic syndrome. Wearing tight (compression) stockings during and after the DVT may help prevent this problem.
A blood clot that breaks free in the leg and travel to the lungs (pulmonary embolus) can be life threatening. Rapid treatment of DVT helps prevent this problem.
Call your health care provider if you have symptoms of DVT.
Go to the emergency room or call the local emergency number (such as 911) if you have DVT and you develop chest pain, difficulty breathing, coughing blood, fainting, loss of consciousness, or other severe symptoms.
|
|
Reviewer Info: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.; ADAM Health Illustrated Encyclopedia, 01/27/2009 |